CALL US: (314) 649-7867

INSYNERGY IN THE NEWS

Women are now drinking just as much as men to cope with stress

ST. LOUIS – Women closed the gap and it’s not a good one. The latest data from more than one source indicates women are drinking just as much as men and it’s not for pleasure but to cope with life’s stresses.

www.fox2now.com

INSynergy Personalized Addiction Care Provides Safe and Effective Recovery

INSynergy’s second program is a comprehensive experience that lasts three months and includes access to psychiatrists, psychologists, addiction counselors, registered nurses and social workers.

www.laduenews.com

INSynergy Leads Medical Innovation to Fight Pandemic Addictions

INSynergy offers personalized programs for those seeking addiction care. Some patients respond well to a 10-day medically supervised detox program, while others need a more intensive 3-month program led by a team of addiction experts.
 

INSynergy Personalized Addiction Care Provides Safe and Effective Recovery

INSynergy’s second program is a comprehensive experience that lasts three months and includes access to psychiatrists, psychologists, addiction counselors, registered nurses and social workers.
 

The Bridge Device

Today, we take a look at a new device available in Fairbanks that could be the missing link in helping opioid addicts with detox. Sarah Dubowski Investigates.
 

Heroin Withdrawal Gets Pioneering Treatment from St. Louis Doctor

To break a heroin habit, an addict must live through the personal hell known as withdrawal. Like a debilitating flu, the process afflicts the body with fever, tremors, nausea, muscle aches and …
 

Taking the Pain Out of Addiction | NOVA | PBS

A Start The Bridge looks like an oversized hearing aid festooned with wires. It releases a small electrical signal that targets the amygdala, a part of the brain that’s rich in opioid receptors …
 

Non-Invasive Medical Device May Improve Opioid Withdrawal Success - Practical Pain Management: Chronic Pain Treatment & Research

Interviews with Arturo Taca, MD, and Tiziano Marovino, DPT, MPH. The US Food and Drug Administration granted marketing approval to Innovative Health Solutions, Inc for the Bridge following submission of an open-label pilot study in which nearly 89% of participants (n = 73) successfully transitioned to naltrexone. 2 The Bridge was developed to interrupt pain and
 

Agency: Device will block opioid withdrawal symptoms

Often the biggest barrier to getting a person started down the road of recovery from opiate addiction is a fear of going through the withdrawal phase.